<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02275819</url>
  </required_header>
  <id_info>
    <org_study_id>E1423-P</org_study_id>
    <nct_id>NCT02275819</nct_id>
  </id_info>
  <brief_title>Exercise Training in Heart Failure: Changes in Cardiac Structure and Function</brief_title>
  <official_title>Exercise Training in Heart Failure: Structural and Functional Cardiac Remodeling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a research study being conducted to better understand the impact of exercise training&#xD;
      on changes on the structure and function of the heart. Exercise training in patients with&#xD;
      heart failure has been shown to be beneficial at decreasing symptoms of heart failure and&#xD;
      improving overall functional capacity or capacity to exercise. However the mechanisms&#xD;
      responsible for this are still unclear. This study will look specifically at how exercise&#xD;
      creates changes within the hearts filling ability, the hearts pumping strength as well as the&#xD;
      hearts ability to rebuild.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prevalence of systolic heart failure (HF) is high among the growing population of older&#xD;
      adults. Progressive cardiac remodeling and deteriorating cardiac output have been implicated&#xD;
      as key factors underlying HF-related exercise intolerance and quality of life. Even after&#xD;
      implementing medical and device therapies that moderate remodeling, exercise tolerance&#xD;
      remains impaired. While exercise training has been demonstrated to improve exercise capacity,&#xD;
      mechanisms facilitating this benefit remain unclear. Peripheral adaptations in the skeletal&#xD;
      muscle and vasculature provide at least some benefit, however reverse cardiac remodeling&#xD;
      (beyond effects of pharmacological and device therapies) may be additive. The investigators&#xD;
      propose to study the impact of 2 different types of exercise on cardiac morphology as well as&#xD;
      systolic and diastolic performance and related functional gains. The investigators will&#xD;
      compare traditional aerobic training to a novel regimen of inspiratory muscle training (IMT).&#xD;
      IMT is a specific type of exercise training that may be particularly useful for frail,&#xD;
      infirmed HF patients who are unlikely to tolerate aerobic training. Effects of IMT on&#xD;
      remodeling have not been previously studied.&#xD;
&#xD;
      The proposed echocardiography pilot study builds on a funded VA Merit F0834-R &quot;Exercise&#xD;
      Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit&quot; (Exercise therapy)&#xD;
      PI, Forman that compares different modes of exercise training in older (age 50yrs) systolic&#xD;
      (EF 45%) HF patients. The original study assesses peripheral mechanisms affected by exercise&#xD;
      training, but was not designed to assess cardiac remodeling. The proposed pilot study&#xD;
      provides a vital complementary analysis, i.e., it adds assessments of cardiac remodeling as&#xD;
      well as related changes in systolic and diastolic performance.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 6, 2016</start_date>
  <completion_date type="Actual">April 23, 2019</completion_date>
  <primary_completion_date type="Actual">April 23, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Non-randomized case control study with two groups. One group received exercise and the controls did not.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Left Ventricular Systolic Function.</measure>
    <time_frame>Baseline and endpoint at 3-5 months</time_frame>
    <description>Change in left ventricular ejection fraction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Left Ventricular Structure.</measure>
    <time_frame>Baseline and endpoint at 3-5 months</time_frame>
    <description>Change in left ventricular mass.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Diastolic Function.</measure>
    <time_frame>Baseline and endpoint at 3-5 months</time_frame>
    <description>Change in mitral annular early diastolic velocity (e')</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Left Ventricular (LV) Diastolic Function</measure>
    <time_frame>Baseline and endpoint at 3-5 months</time_frame>
    <description>Change in the ratio of early mitral in-flow velocity (E) to mitral annular early diastolic velocity (e')</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Right Ventricular Function</measure>
    <time_frame>Baseline and endpoint at 3-5 months</time_frame>
    <description>Change in tricuspid annular tissue doppler velocity</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Will not receive intervention with exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 groups will receive 2 different types of therapy (exercise or Inspiratory Muscle Therapy)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Exercise (walking 3 times a week for 60 minutes) or Inspiratory Muscle Therapy (breathing against an inspiratory resistive load 3 times a week for up to 60 minutes)</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  New York Heart Association (NYHA) class II or III for the previous three months&#xD;
             despite a minimum of 6 weeks of optimal treatment.&#xD;
&#xD;
          -  Age &gt;50 years.&#xD;
&#xD;
          -  Left Ventricular Ejection Fraction (LVEF)&lt;45% (by echocardiogram or radionucleotide&#xD;
             imaging study within 6 months of enrollment). If a patient has initiated or received&#xD;
             any therapy that might improve the ejection fraction, the qualifying EF must be&#xD;
             assessed after the patient is on a stable dose of these therapies. Additionally the&#xD;
             LVEF of &lt;45% will be confirmed with a brief echocardiogram prior to randomization. If&#xD;
             LVEF is not 45%, the patient will not be enrolled in to the study.&#xD;
&#xD;
          -  Optimal therapy according to the American Heart Association (AHA)/American College of&#xD;
             Cardiology (ACC) and the Heart Failure Society of America (HFSA) Heart Failure (HF)&#xD;
             guidelines, including treatment with an angiotensin-converting-enzyme (ACE) Inhibitor&#xD;
             (or an angiotensin receptor blocker) and beta-blocker therapy (for at least 6 weeks),&#xD;
             or have documented reason for variation, including medication intolerance,&#xD;
             contraindication, patient preference, or personal physician's judgment.&#xD;
&#xD;
        In addition to the above we have now added patients with heart failure with preserved&#xD;
        ejection fraction (similar to the parent study )pending Institutional Review Board (IRB)&#xD;
        review.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Major cardiovascular event or procedure within the prior 6 weeks.&#xD;
&#xD;
          -  Dementia.&#xD;
&#xD;
          -  Severe chronic obstructive pulmonary disease (COPD) (FEV1&lt;50%), peripheral vascular&#xD;
             disease (PVD), and/or Anemia.&#xD;
&#xD;
          -  End-stage malignancy.&#xD;
&#xD;
          -  Severe valvular heart disease.&#xD;
&#xD;
          -  Orthopedic exercise limitation.&#xD;
&#xD;
          -  Women who are pregnant, breastfeeding, or likely to become pregnant within the next 6&#xD;
             months.&#xD;
&#xD;
          -  Psychiatric hospitalization within the last 3 months.&#xD;
&#xD;
          -  Implantable Cardioverter Defibrillator (ICD) device with heart rate limits that&#xD;
             prohibit exercise assessments or exercise training. Referring physicians will be&#xD;
             provided with an opportunity to reprogram devices so that patients can participate.&#xD;
&#xD;
          -  Chronic ethyl alcohol (ETOH) or drug dependency.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jayashri Aragam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>October 3, 2014</study_first_submitted>
  <study_first_submitted_qc>October 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2014</study_first_posted>
  <results_first_submitted>November 13, 2020</results_first_submitted>
  <results_first_submitted_qc>March 4, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 8, 2021</results_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Exercise</keyword>
  <keyword>Echocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 13, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/19/NCT02275819/ICF_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 20, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/19/NCT02275819/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment occurred at VA Boston Healthcare System cardiology related clinics from 6/6/2016 to 12/21/2018. As per the protocol the recruitment was supposed to begin in 2014. Unfortunately there were a number of issues including the fact that the parent study moved to Pittsburgh and we were not able to start recruitment till 2016.</recruitment_details>
      <pre_assignment_details>13 participants were consented but only 11 were enrolled. Two were excluded from randomization due to subsequent echocardiogram or pulmonary function screening not meeting enrollment criteria. One was withdrawn after enrollment due to increasing symptoms of heart failure.&#xD;
Due to the small number of participants enrolled in each of the active intervention arms we combined participants from both intervention groups and analyzed against the controls.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>Will not receive intervention with exercise</description>
        </group>
        <group group_id="P2">
          <title>Intervention Group</title>
          <description>2 groups will receive 2 different types of exercise</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Will not receive intervention with exercise</description>
        </group>
        <group group_id="B2">
          <title>Intervention Group</title>
          <description>2 groups will receive 2 different types of exercise</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
            <count group_id="B2" value="5"/>
            <count group_id="B3" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.6" spread="8.4"/>
                    <measurement group_id="B2" value="67.2" spread="4.4"/>
                    <measurement group_id="B3" value="68.4" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Left Ventricular Systolic Function.</title>
        <description>Change in left ventricular ejection fraction.</description>
        <time_frame>Baseline and endpoint at 3-5 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Will not receive intervention with exercise</description>
          </group>
          <group group_id="O2">
            <title>Intervention Group</title>
            <description>2 groups will receive 2 different types of exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Left Ventricular Systolic Function.</title>
          <description>Change in left ventricular ejection fraction.</description>
          <units>percent LVEF</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".82" spread="3.54"/>
                    <measurement group_id="O2" value="-1.90" spread="1.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.14</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Left Ventricular Structure.</title>
        <description>Change in left ventricular mass.</description>
        <time_frame>Baseline and endpoint at 3-5 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Will not receive intervention with exercise</description>
          </group>
          <group group_id="O2">
            <title>Intervention Group</title>
            <description>2 groups will receive 2 different types of exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Left Ventricular Structure.</title>
          <description>Change in left ventricular mass.</description>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-34.8" spread="49.8"/>
                    <measurement group_id="O2" value="3.1" spread="40.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.22</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Diastolic Function.</title>
        <description>Change in mitral annular early diastolic velocity (e')</description>
        <time_frame>Baseline and endpoint at 3-5 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Will not receive intervention with exercise</description>
          </group>
          <group group_id="O2">
            <title>Intervention Group</title>
            <description>2 groups will receive 2 different types of exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Diastolic Function.</title>
          <description>Change in mitral annular early diastolic velocity (e')</description>
          <units>centimeters/second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".31" spread=".68"/>
                    <measurement group_id="O2" value="-1.07" spread="1.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.12</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Left Ventricular (LV) Diastolic Function</title>
        <description>Change in the ratio of early mitral in-flow velocity (E) to mitral annular early diastolic velocity (e')</description>
        <time_frame>Baseline and endpoint at 3-5 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Will not receive intervention with exercise</description>
          </group>
          <group group_id="O2">
            <title>Intervention Group</title>
            <description>2 groups will receive 2 different types of exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Left Ventricular (LV) Diastolic Function</title>
          <description>Change in the ratio of early mitral in-flow velocity (E) to mitral annular early diastolic velocity (e')</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.85" spread="3.06"/>
                    <measurement group_id="O2" value="2.68" spread="3.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.08</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Right Ventricular Function</title>
        <description>Change in tricuspid annular tissue doppler velocity</description>
        <time_frame>Baseline and endpoint at 3-5 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Will not receive intervention with exercise</description>
          </group>
          <group group_id="O2">
            <title>Intervention Group</title>
            <description>2 groups will receive 2 different types of exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Right Ventricular Function</title>
          <description>Change in tricuspid annular tissue doppler velocity</description>
          <units>centimeters/second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="1.04"/>
                    <measurement group_id="O2" value="-0.70" spread="2.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.43</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected while participants were enrolled from enrollment until collection of the final study endpoint at 3-5 months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>Will not receive intervention with exercise</description>
        </group>
        <group group_id="E2">
          <title>Intervention Group</title>
          <description>2 groups will receive 2 different types of exercise</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>HF exacerbation</sub_title>
                <description>Patient reported swelling and edema in legs. Reported to ER and was admitted.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Low BP</sub_title>
                <description>Patient had low BP of 70/50 during a study visit. All other measures were in normal range. Had been taking additional diuretic and additional exercise. Patient was evaluated by cardiologist and sent home for dehydration.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>A-fib Hospitalization</sub_title>
                <description>Patient was admitted to non-VA hospital for A-fib. Treated with Amiodarone drip and cardioversion.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ER Visit</sub_title>
                <description>Patient had flu like symptoms and started coughing up blood. Patient treated with Tamiflu and sent home.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Not Fasted</sub_title>
                <description>Patient was not fasted at baseline visit. Patient completed fast blood draw on first day of intervention instead of during baseline visit. He confirmed he was fasted.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Participation in this study hinged on recruitment into the parent study which was delayed due to various location and staff changes and early termination.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Jayashri Aragam</name_or_title>
      <organization>VA Boston Healthcare System</organization>
      <phone>617-323-7700</phone>
      <email>Jayashri.Aragam@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

